Latest filingSep 04, 2026Most recent Form 4
JNJ
JOHNSON & JOHNSON
NYSEHealthcarePharmaceutical Preparations
Insider activity for last month from 08/04 to 09/04. Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.
Total buying$00 buys
Total selling$1.31B3 sells
Net open-market-$1.31B2 insiders
Open-market mix
Buy vs sell distribution by transaction countInsider activity report
Monthly open-market purchase and sale counts Buys Sells
Transaction codes
By Form 4 transaction code in selected period9transactions
- M · Option exercise · dominant6 · 67%
- S · Open-market sells3 · 33%
Activity by reported role
A joint filing can contribute to multiple roles18transactions
- EVP · dominant9 · 50%
- CHAIR6 · 33%
- WIM3 · 17%
Distinct insiders active
Reporting-owner CIKs by month · peak Aug 2026 (1)Aug 2026Sep 2026
Reported Holdings After
Separated by insider, security, and ownership typeSchmid TimothyCommon Stock · Direct
25,447Sep 02, 2026
Taubert Jennifer LCommon Stock · Direct
194,451.001Aug 17, 2026
Schmid TimothyEmployee Stock Options (Right to Buy) · Direct
0Sep 02, 2026
Taubert Jennifer LEmployee Stock Options (Right to Buy) · Direct
28,712Aug 17, 2026
These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.
Filing activity heatmap
Each cell is one day · intensity = transactions · buys green, sells redAug 04 → Sep 04
LessMore
Top insiders
By absolute net value across the selected period- ST-$9.2M
- TL-$4.0M
Filing detail checks
Secondary metrics for the selected periodFiling-only signals
Deterministic matches in the selected period
JNJ transaction history
Filters apply within this company and selected period by default| Ticker | Insider | Role | Type | Shares | Value | Code | Signals | 90d return | Filed | Trans date |
|---|---|---|---|---|---|---|---|---|---|---|
| JNJ | Schmid Timothy | EVPCHAIR | sale | 22.5k | -$618M | S | — | 0.0% | 09/04 | 09/02 |
| JNJ | Schmid Timothy | EVPCHAIR | sale | 11.0k | -$304M | S | — | 0.0% | 09/04 | 09/02 |
| JNJ | Taubert Jennifer L | EVPWIM | sale | 15.0k | -$395M | S | +0.0% | 08/18 | 08/17 |
JOHNSON & JOHNSON Insider Activity FAQ
SEC Form 4 contextWho recently reported transactions at JOHNSON & JOHNSON?
Schmid Timothy, Taubert Jennifer L.
When was the latest reported open-market purchase?
No code-P purchase is available for this period.
When was the latest reported open-market sale?
Schmid Timothy reported a sale on Sep 02, 2026 valued at $618M. Read the SEC filing.
What is the recent purchase and sale balance?
Net open-market selling in the selected period was $13,180,839.78. Sales can occur for many non-investment reasons.
Where can I see the original SEC filing?
Every transaction row and latest-activity fact links to its original SEC filing.
What do these Form 4 transaction codes mean?
P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.